DelveInsight recently conducted an in-depth MASH Market Size and Share Assessment to help a pharmaceutical client understand the evolving Metabolic Dysfunction-Associated Steatohepatitis (MASH) market ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other ...

The global veterinary dermatology market, valued at US$18.59 billion in 2024, is forecasted to grow at a robust CAGR of 8.5%, reaching US$20.11 ...

The health secretary has since told lawmakers that he has referred hundreds of clients to the law firm suing vaccine-maker Merck in an arrangement where he would be entitled to 10% of contingency ...

LOS ANGELES, CA / ACCESS Newswire / February 27, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Merck & Co., Inc ...

Reuters FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in ... focus on multiple therapy areas including oncology, diabetes, vaccines and animal health, as well as ...

Find out how to access funding for vet services through Defra's animal health and welfare review and endemic disease follow-up. Announced in June, the animal health and welfare review (formerly the ...

Drugmaker Merck, known as MSD outside of the U.S. and Canada, expects to increase its workforce across its India sites by the end of the year, a senior company executive said on Wednesday. The U.S.

Merck's India sites, which together employ around 1,800 people, focus on multiple therapy areas including oncology, diabetes, vaccines and animal health, as well as technology-related centers.